Related Experiment Video
Updated: Jul 16, 2025

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.0K
[Bronchoscopic COPD treatments]
Revue Des Maladies Respiratoires
|September 8, 2023
Summary
Endoscopic treatments offer new hope for chronic obstructive pulmonary disease (COPD) patients. Further research is needed to confirm the safety and efficacy of these innovative lung volume reduction strategies.
Area of Science:
- Pulmonology
- Interventional Pulmonology
- Medical Devices
Context:
- Chronic obstructive pulmonary disease (COPD) presents significant challenges with limited treatment options.
- Endoscopic lung volume reduction (ELVR) techniques are emerging as promising interventional strategies.
- Current therapies for COPD symptoms like dyspnea and exacerbations have restricted efficacy.
Purpose:
- To review the current landscape of endoscopic treatments for COPD.
- To evaluate the status and potential of various endoscopic lung volume reduction techniques.
- To highlight the need for further research and patient stratification for endoscopic COPD therapies.
Summary:
- Endobronchial valves are established for selected COPD patients without collateral ventilation.
- Other ELVR methods like polymers, thermal vapor, and spirals require more investigation.
- Targeted lung denervation (TLD) shows potential for reducing exacerbations, while cryospray and rheoplasty are in early development for chronic bronchitis symptoms.
Impact:
- Endoscopic treatments represent a significant area of innovation for COPD management.
- Clinical trials and patient registries are crucial for assessing the benefit-risk profile of these interventions.
- Identifying optimal patient candidates will maximize the effectiveness of future endoscopic COPD therapies.
Keywords:
Bronchite chroniqueBronchopneumopathie chronique obstructiveBronchoscopieBronchoscopyChronic bronchitisChronic obstructive pulmonary diseaseEmphysemaEmphysèmeInterventionalInterventionnelMore Related Videos
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
241
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
241
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Drugs Used in Lower Respiratory Disorders: Overview
481
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
481
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K

